IDIOPATHIC ANAPHYLAXIS SUCCESSFULLY TREATED WITH OMALIZUMAB

被引：42

作者：

Jones, Jeremy D. ^{[1
]}

Marney, Samuel R., Jr. ^{[1
]}

Fahrenholz, John M. ^{[1
]}

机构：

[1] Vanderbilt Univ, Allergy Program, Nashville, TN USA

来源：

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2008年 / 101卷 / 05期

关键词：

D O I：

10.1016/S1081-1206(10)60296-7

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：550 / 551

页数：2

共 8 条

[1] EVALUATION OF SEVERE (ANAPHYLACTIC) REACTIONS [J].

BACAL, E ;

PATTERSON, R ;

ZEISS, CR .

CLINICAL ALLERGY, 1978, 8 (03) :295-304

[2] Anti-IgE as a mast cell-stabilizing therapeutic agent [J].

Chang, TW ;

Shiung, YY .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (06) :1203-1212

[3] Idiopathic anaphylaxis [J].

Greenberger, Paul A. .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2007, 27 (02) :273-+

[4] Effect of omalizumab in health care workers with occupational latex allergy [J].

Leynadier, F ;

Doudou, O ;

Gaouar, H ;

Le Gros, V ;

Bourdeix, I ;

Guyomarch-Cocco, L ;

Trunet, P .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (02) :360-361

[5]

MAJMUNDAR A, 2005, J ALLERGY CLIN IM S1, V115, pS38

[6] Efficacy of Omalizumab for the treatment of allergic urticaria and angioedema [J].

Rafi, A. ;

Do, L. ;

Mangat, R. ;

Sender, S. ;

Katz, R. M. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :S312-S312

[7] A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of XOLAIR® (omalizumab) in peanut allergy (TOPS) [J].

Sampson, H. A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :S117-S117

[8] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab) [J].

Shapiro, C. A. ;

Kapetanos, N. S. ;

Sarmiento, E. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) :S274-S274

← 1 →